<!-- CoverPageHeader start -->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE> Hansen Medical, Inc. (Form: 8-K) </TITLE>
</HEAD>
<BODY TEXT="#000000" BGCOLOR="#FFFFFF" ALINK="#0000FF" HLINK="#FF0000" VLINK="#800080">
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<P>
<!-- CoverPageHeader end --><!-- CoverPageTitle START -->
<A NAME="DOCUMENT_TOP">&nbsp;</A>
<HR NOSHADE>
<P>
<P ALIGN="CENTER">
<FONT SIZE="4">
		UNITED STATES<BR>
	SECURITIES AND EXCHANGE COMMISSION
</FONT>
<BR>
<FONT SIZE="2">
	WASHINGTON, D.C. 20549
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="5">
	FORM 8-K
</FONT>
<FONT SIZE="2">

</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="3">
	CURRENT REPORT
</FONT>
</P>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
</FONT>
</P>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Date of Report (Date of Earliest Event Reported):
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	July 22, 2016
</FONT>
</TD>
</TR>
</TABLE>
<BR>
</CENTER>
<!-- CoverPageTitle END --><!-- CoverPageRegistrant START -->
<P ALIGN="CENTER"><!-- -->
<FONT SIZE="6">
	Hansen Medical, Inc.
</FONT>
<FONT SIZE="2">
<BR>__________________________________________<BR>
	(Exact name of registrant as specified in its charter)
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="33%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="33%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Delaware
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	001-33151
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	14-1850535
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________________<BR>
	(State or other jurisdiction
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_____________<BR>
	(Commission
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
______________<BR>
	(I.R.S. Employer
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	of incorporation)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	File Number)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Identification No.)
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	800 East Middlefield Road, Mountain View, California
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	94043
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
_________________________________<BR>
	(Address of principal executive offices)
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
___________<BR>
	(Zip Code)
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">

<TR VALIGN="BOTTOM">
<TD WIDTH="51%">
	&nbsp;
</TD>
<TD WIDTH="5%">
	&nbsp;
</TD>
<TD WIDTH="44%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	Registrant&#146;s telephone number, including area code:
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="CENTER" VALIGN="TOP">
<FONT SIZE="2">
	(650) 404-5800
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<P ALIGN="CENTER">
<FONT SIZE="2">
	Not Applicable
<BR>______________________________________________<BR>
	Former name or former address, if changed since last report
</FONT>
<P ALIGN="CENTER">
<FONT SIZE="2">
	&nbsp;
</FONT>
<!-- CoverPageRegistrant END --><P><FONT SIZE="2">
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:</FONT>
</P>
<P><FONT SIZE="2">
[&nbsp;&nbsp;]&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<br>
[&nbsp;&nbsp;]&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<br>
</P></FONT><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END -->



<P align="left" style="font-size: 10pt"><FONT style="font-size: 10pt"><B>Introductory Note.</B>
</FONT>

<P align="left" style="font-size: 10pt">As previously announced, Hansen Medical, Inc., a Delaware corporation (&#147;<U>Hansen</U>&#148;), entered
into that certain Agreement and Plan of Merger dated as of April&nbsp;19, 2016 (the &#147;<U>Merger
Agreement</U>&#148;), with Auris Surgical Robotics, Inc., a Delaware corporation (&#147;<U>Auris</U>&#148;), and
Pineco Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Auris
(&#147;<U>Merger Sub</U>&#148;).


<P align="left" style="font-size: 10pt">On July&nbsp;22, 2016, Hansen held its 2016 annual meeting of stockholders (the &#147;<U>Annual
Meeting</U>&#148;), at which its stockholders approved, among other things as set forth in Item&nbsp;5.07 of
this Current Report on Form 8-K, the adoption of the Merger Agreement in accordance with the
Delaware General Corporation Law (the &#147;<U>DGCL</U>&#148;). Following the stockholder approval, pursuant
to the Merger Agreement, on July&nbsp;27, 2016, Merger Sub merged with and into Hansen (the
&#147;<U>Merger</U>&#148;) with Hansen continuing as the surviving corporation and a wholly-owned subsidiary
of Auris. The information set forth in Item&nbsp;5.07 regarding the results of the vote at the Annual
Meeting is incorporated by reference into this Introductory Note.


<P align="left" style="font-size: 10pt">The description of the Merger Agreement and the Merger in this Introductory Note does not purport
to be complete and is qualified in its entirety by reference to the Merger Agreement, a copy of
which was filed as Exhibit&nbsp;2.1 to Hansen&#146;s Current Report on Form 8-K filed with the Securities and
Exchange Commission (the &#147;<U>SEC</U>&#148;) on April&nbsp;20, 2016, and is hereby incorporated into this
Current Report on Form 8-K by reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;1.02 Termination of a Material Definitive Agreement.</B>


<P align="left" style="font-size: 10pt">On July&nbsp;27, 2016, in connection with the Merger, Hansen (utilizing funds provided to it by Auris
for such purpose) repaid in full the outstanding principal amount, together with interest and all
other amounts due, under the Amended and Restated Loan and Security Agreement dated as of August
23, 2013 (the &#147;<U>White Oak Agreement</U>&#148;), among Hansen, as borrower, the entities from time to
time party thereto as lenders, and White Oak Global Advisors, LLC, as agent (&#147;<U>White Oak</U>&#148;),
as supplemented by the Forbearance Agreement dated as of April&nbsp;19, 2016, by and between Hansen and
White Oak. Effective upon receipt of such payment, the White Oak Agreement and the other related
loan documents were terminated and have no further force or effect (except with respect to those
provisions of any loan document which by their express terms survive the termination) and all liens
granted under the White Oak Agreement were released. No penalties were due in connection with such
repayment.


<P align="left" style="font-size: 10pt">The foregoing description of the White Oak Agreement and the Forbearance Agreement is qualified in
its entirety by reference to the White Oak Agreement, a copy of which was filed as Exhibit&nbsp;10.3 to
Hansen&#146;s Quarterly Report on Form 10-Q filed with the SEC on November&nbsp;8, 2013, and the Forbearance
Agreement, a copy of which was filed as Exhibit&nbsp;10.1 to Hansen&#146;s Current Report on Form 8-K filed
with the SEC on April&nbsp;20, 2016, both of which are hereby incorporated into this Current Report on
Form 8-K by reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;2.01 Completion of Acquisition or Disposition of Assets.</B>


<P align="left" style="font-size: 10pt">On July&nbsp;27, 2016, Hansen and Auris consummated the transactions contemplated by the Merger
Agreement. The Merger became effective on such date upon the filing of the certificate of merger
with the Secretary of State of the State of Delaware (the &#147;<U>Effective Time</U>&#148;). At the
Effective Time, each share of Hansen common stock, par value $0.0001 per share (&#147;<U>Common
Stock</U>&#148;), issued and outstanding immediately prior to the Effective Time, other than shares
owned by Auris or any of its subsidiaries, shares held by Hansen as treasury stock, and shares held
by stockholders, if any, who validly perfected their statutory rights of appraisal under
Section&nbsp;262 of the DGCL, converted into the right to receive $4.00 in cash, without interest and
less any applicable withholding taxes (the &#147;<U>Merger Consideration</U>&#148;).


<P align="left" style="font-size: 10pt">Immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock
granted under a Hansen stock plan was cancelled for no consideration. Additionally, immediately
prior to the Effective Time, each outstanding award of restricted stock units with respect to
shares of Common Stock (each, an &#147;<U>RSU Award</U>&#148;) granted pursuant to a Hansen stock plan
became fully vested and was cancelled and, in exchange therefor, each holder of any such cancelled
RSU Award became entitled to receive, in consideration of the cancellation of such RSU Award and in
settlement therefor, a payment in cash of an amount equal to the product of (i)&nbsp;the Merger
Consideration multiplied by (ii)&nbsp;the number of restricted stock units subject to such RSU Award,
without interest and less any required tax withholdings. To the extent an RSU Award was subject to
performance conditions, the number of restricted stock units that vest was determined (A)&nbsp;for RSU
Awards with a performance period that by its terms ended prior to the Effective Time, based on
actual performance through the end of such performance period, and (B)&nbsp;for RSU Awards with a
performance period that by its terms did not end prior to the Effective Time, by deeming such
performance conditions to have been satisfied at 100% of the target levels specified in the
applicable equity plans and award agreements.


<P align="left" style="font-size: 10pt">Immediately following the Effective Time, certain former Hansen stockholders owning approximately
64.6% of the shares of Common Stock outstanding as of May&nbsp;31, 2016, the record date for the Annual
Meeting, including Larry Feinberg and certain affiliated entities, Jack Schuler and certain
affiliated entities and an affiliated entity of Lawrence T. Kennedy, Jr. (the &#147;<U>Rollover
Stockholders</U>&#148;), acquired shares of preferred stock of Auris on the terms set forth in a stock
purchase agreement entered into among the Rollover Stockholders and Auris concurrently with the
Merger Agreement , in exchange for an investment of approximately $49&nbsp;million (representing the
aggregate amount of consideration payable to the Rollover Stockholders in the Merger).


<P align="left" style="font-size: 10pt">The foregoing description of the Merger, the Merger Agreement, the RSU Awards and the Rollover
Stockholders does not purport to be complete and is qualified in their entirety by reference to the
Merger Agreement, a copy of which is filed as Exhibit&nbsp;2.1 to Hansen&#146;s Current Report on Form 8-K
filed with the SEC on April&nbsp;20, 2016, and is hereby incorporated into this Current Report on Form
8-K by reference.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;3.01</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Notice of Delisting or a Failure to Satisfy a Continued Listing Rule or Standard;
Transfer of Listing.</B></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">The information set forth in Item&nbsp;2.01 of this Current Report on Form 8-K is incorporated into this
Item&nbsp;3.01 by reference.


<P align="left" style="font-size: 10pt">On July&nbsp;27, 2016, in connection with the consummation of the Merger, Hansen notified The NASDAQ
Stock Market (&#147;<U>NASDAQ</U>&#148;) of the consummation of the Merger and requested that NASDAQ file
with the SEC an application on Form&nbsp;25 Notification of Removal from Listing and/or Registration to
delist and deregister the Common Stock under Section 12(b) of the Securities Exchange Act of 1934,
as amended (the &#147;<U>Exchange Act</U>&#148;). Hansen intends to file with the SEC a Form&nbsp;15 requesting
the deregistration of Common Stock under Section 12(g) of the Exchange Ac and the suspension of
Hansen&#146;s reporting obligations under Section&nbsp;13 and Section 15(d) of the Exchange Act.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;3.03</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Material Modification to Rights of Security Holders.</B></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">The information set forth in Items 2.01 and 3.01 of this Current Report on Form 8-K is incorporated
into this Item&nbsp;3.03 by reference.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;5.01</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Changes in Control of Registrant.</B></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">The information set forth in Items 2.01 and 5.02 of this Current Report on Form 8-K is incorporated
into this Item&nbsp;5.01 by reference.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;5.02</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Agreements of Certain Officers.</B></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">In accordance with the terms of the Merger Agreement, each member of the board of directors of
Hansen (the &#147;<U>Board</U>&#148;), including Marjorie L. Bowen, Kevin Hykes and Nadim Yared, each of
whom was re-elected as a member of the Board at the Annual Meeting held on July&nbsp;22, 2016, and
Michael L. Eagle, Christopher P. Lowe, Dr.&nbsp;Stephen L. Newman, William R. Rohn and Cary G. Vance,
resigned as directors of Hansen, effective as of the Effective Time. In accordance with the terms
of the Merger Agreement, at the Effective Time, the sole director of the Merger Sub immediately
prior to the Effective Time, David Styka, became the sole director of Hansen.


<P align="left" style="font-size: 10pt">In accordance with the terms of the Merger Agreement, Cary G. Vance, Chief Executive Officer of
Hansen, and Christopher P. Lowe, Chief Financial Officer of Hansen, each resigned as officers of
Hansen effective as of the Effective Time. In accordance with the terms of the Merger Agreement, at
the Effective Time, Frederic Moll and David Styka, each an officer of Merger Sub prior to the
Merger, became Chief Executive Officer and Chief Financial Officer of Hansen, respectively.


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;5.03</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</B></TD>
</TR>

</TABLE>


<P align="left" style="font-size: 10pt">In connection with the consummation of the Merger, at the Effective Time, the certificate of
incorporation and bylaws of Hansen were each amended and restated to be identical to the
certificate of incorporation and bylaws of Merger Sub as in effect immediately prior to the
Effective Time (except that references to the name of Merger Sub were replaced by references to the
name of Hansen). Copies of the amended and restated certificate of incorporation and amended and
restated bylaws are attached hereto as Exhibits 3.1 and 3.2, respectively, and incorporated herein
by reference.


<P align="left" style="font-size: 10pt"><B>Item&nbsp;5.07 Submission of Matters to a Vote of Security Holders.</B>


<P align="left" style="font-size: 10pt">Hansen held its 2016 annual meeting of stockholders (the &#147;<U>Annual Meeting</U>&#148;) on July&nbsp;22,
2016.


<P align="left" style="font-size: 10pt">As of the record date, May&nbsp;31, 2016, there were 18,989,610 shares of Common Stock outstanding and
entitled to vote at the Annual Meeting. At the Annual Meeting, a total of 17,725,358 shares of
Common Stock, or approximately 93.34% of all of the outstanding shares of Common Stock, were
present either in person or by proxy. The number of votes cast for, against or withheld, as well as
abstentions and broker non-votes, as applicable, with respect to each proposal that was voted upon
at the Annual Meeting is set forth below. The proposals are described in detail in Hansen&#146;s
definitive proxy statement filed with the SEC on June&nbsp;20, 2016.


<P align="left" style="font-size: 10pt"><B>Proposal 1. </B>Adoption of the Merger Agreement, which provides for the Merger in which Hansen became
a wholly owned subsidiary of Auris. Hansen&#146;s stockholders approved Proposal 1 with the following
voting results:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>BROKER</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 10pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 8pt"><B>FOR</B></FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>AGAINST</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>ABSTAIN</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>NON-VOTE</B></FONT>
</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 8pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 10pt">14,083,958</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">109,340</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2,963</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3,529,097</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt"><B>Proposal 2. </B>Non-binding advisory approval of the compensation that may be paid or become payable to
Hansen&#146;s named executive officers that is based on or otherwise relates to the Merger contemplated
by the Merger Agreement. Hansen&#146;s stockholders approved Proposal 2 with the following voting
results:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>BROKER</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 10pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 8pt"><B>FOR</B></FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>AGAINST</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>ABSTAIN</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>NON-VOTE</B></FONT>
</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 8pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 10pt">14,027,692</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">157,439</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11,130</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3,529,097</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt"><B>Proposal 3. </B>Approval of the adjournment of the Annual Meeting to a later date or time if necessary
or appropriate, as determined by Hansen, to solicit additional proxies for the adoption of the
Merger Agreement if there are insufficient votes at the time of the Annual Meeting, or any
adjournment or postponement thereof, to adopt the Merger Agreement. Hansen&#146;s stockholders approved
Proposal 3 with the following voting results:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>BROKER</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 10pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 8pt"><B>FOR</B></FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>AGAINST</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>ABSTAIN</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>NON-VOTE</B></FONT>
</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 8pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 10pt">14,013,095</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">179,531</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3,635</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3,529,097</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt"><B>Proposal 4. </B>Election of Directors. The following nominees received the highest number of &#147;FOR&#148;
votes and, as a result, were elected to serve as Class&nbsp;I directors. The votes cast by Hansen&#146;s
stockholders were as follows:

<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="37%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="9%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>NOMINEE</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>FOR</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>WITHHELD</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>BROKER NON-VOTE</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 8pt">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT style="font-size: 10pt">Marjorie L. Bowen</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">13,997,521</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">198,740</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">3,529,097</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT style="font-size: 10pt">Kevin Hykes</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">14,106,675</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">89,586</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">3,529,097</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD><DIV style="margin-left:10px; text-indent:-10px"><FONT style="font-size: 10pt">Nadim Yared</FONT></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">14,105,751</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">90,510</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="right"><FONT style="font-size: 10pt"></FONT></TD>
    <TD align="right"><FONT style="font-size: 10pt">3,529,097</FONT></TD>
    <TD><FONT style="font-size: 10pt"></FONT></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="left" style="font-size: 10pt"><B>Proposal 5</B>. Ratification of the appointment by the Audit Committee of the Board of BDO USA, LLP as
Hansen&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31,
2016. Hansen&#146;s stockholders approved Proposal 5 with the following voting results:

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="17%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>BROKER</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 10pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 8pt"><B>FOR</B></FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>AGAINST</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top"><FONT style="font-size: 8pt"><B>ABSTAIN</B></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt">&nbsp;&nbsp;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><FONT style="font-size: 8pt"><B>NON-VOTE</B></FONT></TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 8pt">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><FONT style="font-size: 10pt">17,402,210</FONT>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">246,287</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">76,861</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#151;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P>
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="right"><B>Item&nbsp;9.01</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD><B>Financial Statements and Exhibits.</B></TD>
</TR>

</TABLE>

&nbsp;

<P align="left" style="font-size: 10pt"><B>(d)&nbsp;Exhibits.</B>

&nbsp;
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="95%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="84%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" colspan="3"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap colspan="3" align="center" valign="top"><B>Number</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>Document</B></DIV></TD>
</TR>
<TR style="font-size: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top" style="border-top: 1px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Agreement and Plan of Merger dated as of April&nbsp;19, 2016, by and among<BR>
Hansen Medical, Inc., Auris Surgical Robotics, Inc. and Pineco<BR>
Acquisition Corp. (incorporated by reference to Exhibit&nbsp;2.1 to the<BR>
Current Report on Form&nbsp;8-K filed by Hansen Medical, Inc. on April&nbsp;20,<BR>
2016).</DIV></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Hansen Medical, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="font-size: 10pt">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">3.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Bylaws of Hansen Medical, Inc.</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt; display: none">




<!-- v.121908 -->

<!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><!-- SignatureHeader START -->
<P ALIGN="CENTER">
<FONT SIZE="2">
<B>
	SIGNATURES
</B>
</FONT>
</P>
<P ALIGN="LEFT">
<FONT SIZE="2">
	Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
</FONT>
</P>
<!-- SignatureHeader END --><!-- Signature START -->
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="100%">
<TR VALIGN="BOTTOM">
<TD WIDTH="19%">
	&nbsp;
</TD>
<TD WIDTH="34%">
	&nbsp;
</TD>
<TD WIDTH="3%">
	&nbsp;
</TD>
<TD WIDTH="1%">
	&nbsp;
</TD>
<TD WIDTH="43%">
	&nbsp;
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD COLSPAN="3" VALIGN="TOP" ALIGN="LEFT">
<FONT SIZE="2">
	Hansen Medical, Inc.
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
<I>
	July 27, 2016
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	By:
</I>
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	/s/ Christopher P. Lowe
</I>
<BR>
</FONT>
</TD>
</TR>
<TR>
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<HR SIZE="1" NOSHADE>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Name: Christopher P. Lowe
</I>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD>
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<FONT SIZE="2">
<I>
	Title: Interim Chief Financial Officer
</I>
</FONT>
</TD>
</TR>
</TABLE>
</CENTER>
<!-- Signature END --><!-- PageBreak START -->
<P>
<HR NOSHADE>
<DIV ALIGN="LEFT" STYLE="PAGE-BREAK-BEFORE:ALWAYS">
<A HREF="#DOCUMENT_TOP">
<U>
<B>
<FONT SIZE="2">Top of the Form</FONT>
</B>
</U>
</A>
</DIV>
<!-- PageBreak END --><P ALIGN="CENTER">
<FONT SIZE="2">
	Exhibit&nbsp;Index
</FONT>
<CENTER>
<TABLE CELLSPACING="0" BORDER="0" CELLPADDING="0" WIDTH="60%">
<TR VALIGN="BOTTOM">
<TD WIDTH="8%">
	&nbsp;
</TD>
<TD WIDTH="15%">
	&nbsp;
</TD>
<TD WIDTH="77%">
	&nbsp;
</TD>
</TR>

<BR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Exhibit No.
</B>
</FONT>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="LEFT">
<FONT SIZE="1">
<B>
	Description
</B>
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD NOWRAP ALIGN="CENTER">
<HR SIZE="1" NOSHADE>
</TD>
<TD>
<FONT SIZE="1">
	&nbsp;
</FONT>
</TD>
<TD NOWRAP ALIGN="CENTER">
<HR ALIGN="LEFT" SIZE="1" WIDTH="88%" NOSHADE>
</TD>
</TR>





<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	3.1
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
Amended and Restated Certificate of Incorporation of Hansen Medical, Inc.
</FONT>
</TD>
</TR>
<TR VALIGN="BOTTOM">
<TD VALIGN="TOP" WIDTH="8%" nowrap>
<FONT SIZE="2">
<DIV ALIGN="LEFT">
	3.2
</DIV>
</FONT>
</TD>
<TD WIDTH="15%">
<FONT SIZE="2">
	&nbsp;
</FONT>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP" WIDTH="77%">
<FONT SIZE="2">
Amended and Restated Bylaws of Hansen Medical, Inc.
</FONT>
</TD>
</TR></TABLE></CENTER><!-- HTMLFooter START -->
</BODY>
</HTML>
<!-- HTMLFooter END -->
[{"type": "8-K", "sequence": "1", "filename": "htm_53859.htm", "description": "LIVE FILING", "secsgml_size_bytes": 48278}]
{"company-data": {"conformed-name": "HANSEN MEDICAL INC", "cik": "0001276591", "assigned-sic": "3842", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33151", "film-number": "161786641"}, "business-address": {"street1": "800 EAST MIDDLEFIELD ROAD", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043", "phone": "650 404 5800"}, "mail-address": {"street1": "800 EAST MIDDLEFIELD ROAD", "city": "MOUNTAIN VIEW", "state": "CA", "zip": "94043"}}
Hansen Medical, Inc. (Form: 8-K)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
July 22, 2016
Hansen Medical, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware
001-33151
14-1850535
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation)
File Number)
Identification No.)
800 East Middlefield Road, Mountain View, California
94043
_________________________________
(Address of principal executive offices)
___________
(Zip Code)
Registrant's telephone number, including area code:
(650) 404-5800
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Top of the Form
Introductory Note.
As previously announced, Hansen Medical, Inc., a Delaware corporation ("
Hansen
"), entered
into that certain Agreement and Plan of Merger dated as of April 19, 2016 (the "
Merger
Agreement
"), with Auris Surgical Robotics, Inc., a Delaware corporation ("
Auris
"), and
Pineco Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Auris
("
Merger Sub
").
On July 22, 2016, Hansen held its 2016 annual meeting of stockholders (the "
Annual
Meeting
"), at which its stockholders approved, among other things as set forth in Item 5.07 of
this Current Report on Form 8-K, the adoption of the Merger Agreement in accordance with the
Delaware General Corporation Law (the "
DGCL
"). Following the stockholder approval, pursuant
to the Merger Agreement, on July 27, 2016, Merger Sub merged with and into Hansen (the
"
Merger
") with Hansen continuing as the surviving corporation and a wholly-owned subsidiary
of Auris. The information set forth in Item 5.07 regarding the results of the vote at the Annual
Meeting is incorporated by reference into this Introductory Note.
The description of the Merger Agreement and the Merger in this Introductory Note does not purport
to be complete and is qualified in its entirety by reference to the Merger Agreement, a copy of
which was filed as Exhibit 2.1 to Hansen's Current Report on Form 8-K filed with the Securities and
Exchange Commission (the "
SEC
") on April 20, 2016, and is hereby incorporated into this
Current Report on Form 8-K by reference.
Item 1.02 Termination of a Material Definitive Agreement.
On July 27, 2016, in connection with the Merger, Hansen (utilizing funds provided to it by Auris
for such purpose) repaid in full the outstanding principal amount, together with interest and all
other amounts due, under the Amended and Restated Loan and Security Agreement dated as of August
23, 2013 (the "
White Oak Agreement
"), among Hansen, as borrower, the entities from time to
time party thereto as lenders, and White Oak Global Advisors, LLC, as agent ("
White Oak
"),
as supplemented by the Forbearance Agreement dated as of April 19, 2016, by and between Hansen and
White Oak. Effective upon receipt of such payment, the White Oak Agreement and the other related
loan documents were terminated and have no further force or effect (except with respect to those
provisions of any loan document which by their express terms survive the termination) and all liens
granted under the White Oak Agreement were released. No penalties were due in connection with such
repayment.
The foregoing description of the White Oak Agreement and the Forbearance Agreement is qualified in
its entirety by reference to the White Oak Agreement, a copy of which was filed as Exhibit 10.3 to
Hansen's Quarterly Report on Form 10-Q filed with the SEC on November 8, 2013, and the Forbearance
Agreement, a copy of which was filed as Exhibit 10.1 to Hansen's Current Report on Form 8-K filed
with the SEC on April 20, 2016, both of which are hereby incorporated into this Current Report on
Form 8-K by reference.
Item 2.01 Completion of Acquisition or Disposition of Assets.
On July 27, 2016, Hansen and Auris consummated the transactions contemplated by the Merger
Agreement. The Merger became effective on such date upon the filing of the certificate of merger
with the Secretary of State of the State of Delaware (the "
Effective Time
"). At the
Effective Time, each share of Hansen common stock, par value $0.0001 per share ("
Common
Stock
"), issued and outstanding immediately prior to the Effective Time, other than shares
owned by Auris or any of its subsidiaries, shares held by Hansen as treasury stock, and shares held
by stockholders, if any, who validly perfected their statutory rights of appraisal under
Section 262 of the DGCL, converted into the right to receive $4.00 in cash, without interest and
less any applicable withholding taxes (the "
Merger Consideration
").
Immediately prior to the Effective Time, each outstanding option to purchase shares of Common Stock
granted under a Hansen stock plan was cancelled for no consideration. Additionally, immediately
prior to the Effective Time, each outstanding award of restricted stock units with respect to
shares of Common Stock (each, an "
RSU Award
") granted pursuant to a Hansen stock plan
became fully vested and was cancelled and, in exchange therefor, each holder of any such cancelled
RSU Award became entitled to receive, in consideration of the cancellation of such RSU Award and in
settlement therefor, a payment in cash of an amount equal to the product of (i) the Merger
Consideration multiplied by (ii) the number of restricted stock units subject to such RSU Award,
without interest and less any required tax withholdings. To the extent an RSU Award was subject to
performance conditions, the number of restricted stock units that vest was determined (A) for RSU
Awards with a performance period that by its terms ended prior to the Effective Time, based on
actual performance through the end of such performance period, and (B) for RSU Awards with a
performance period that by its terms did not end prior to the Effective Time, by deeming such
performance conditions to have been satisfied at 100% of the target levels specified in the
applicable equity plans and award agreements.
Immediately following the Effective Time, certain former Hansen stockholders owning approximately
64.6% of the shares of Common Stock outstanding as of May 31, 2016, the record date for the Annual
Meeting, including Larry Feinberg and certain affiliated entities, Jack Schuler and certain
affiliated entities and an affiliated entity of Lawrence T. Kennedy, Jr. (the "
Rollover
Stockholders
"), acquired shares of preferred stock of Auris on the terms set forth in a stock
purchase agreement entered into among the Rollover Stockholders and Auris concurrently with the
Merger Agreement , in exchange for an investment of approximately $49 million (representing the
aggregate amount of consideration payable to the Rollover Stockholders in the Merger).
The foregoing description of the Merger, the Merger Agreement, the RSU Awards and the Rollover
Stockholders does not purport to be complete and is qualified in their entirety by reference to the
Merger Agreement, a copy of which is filed as Exhibit 2.1 to Hansen's Current Report on Form 8-K
filed with the SEC on April 20, 2016, and is hereby incorporated into this Current Report on Form
8-K by reference.
Item 3.01
Notice of Delisting or a Failure to Satisfy a Continued Listing Rule or Standard;
Transfer of Listing.
The information set forth in Item 2.01 of this Current Report on Form 8-K is incorporated into this
Item 3.01 by reference.
On July 27, 2016, in connection with the consummation of the Merger, Hansen notified The NASDAQ
Stock Market ("
NASDAQ
") of the consummation of the Merger and requested that NASDAQ file
with the SEC an application on Form 25 Notification of Removal from Listing and/or Registration to
delist and deregister the Common Stock under Section 12(b) of the Securities Exchange Act of 1934,
as amended (the "
Exchange Act
"). Hansen intends to file with the SEC a Form 15 requesting
the deregistration of Common Stock under Section 12(g) of the Exchange Ac and the suspension of
Hansen's reporting obligations under Section 13 and Section 15(d) of the Exchange Act.
Item 3.03
Material Modification to Rights of Security Holders.
The information set forth in Items 2.01 and 3.01 of this Current Report on Form 8-K is incorporated
into this Item 3.03 by reference.
Item 5.01
Changes in Control of Registrant.
The information set forth in Items 2.01 and 5.02 of this Current Report on Form 8-K is incorporated
into this Item 5.01 by reference.
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of
Certain Officers; Compensatory Agreements of Certain Officers.
In accordance with the terms of the Merger Agreement, each member of the board of directors of
Hansen (the "
Board
"), including Marjorie L. Bowen, Kevin Hykes and Nadim Yared, each of
whom was re-elected as a member of the Board at the Annual Meeting held on July 22, 2016, and
Michael L. Eagle, Christopher P. Lowe, Dr. Stephen L. Newman, William R. Rohn and Cary G. Vance,
resigned as directors of Hansen, effective as of the Effective Time. In accordance with the terms
of the Merger Agreement, at the Effective Time, the sole director of the Merger Sub immediately
prior to the Effective Time, David Styka, became the sole director of Hansen.
In accordance with the terms of the Merger Agreement, Cary G. Vance, Chief Executive Officer of
Hansen, and Christopher P. Lowe, Chief Financial Officer of Hansen, each resigned as officers of
Hansen effective as of the Effective Time. In accordance with the terms of the Merger Agreement, at
the Effective Time, Frederic Moll and David Styka, each an officer of Merger Sub prior to the
Merger, became Chief Executive Officer and Chief Financial Officer of Hansen, respectively.
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
In connection with the consummation of the Merger, at the Effective Time, the certificate of
incorporation and bylaws of Hansen were each amended and restated to be identical to the
certificate of incorporation and bylaws of Merger Sub as in effect immediately prior to the
Effective Time (except that references to the name of Merger Sub were replaced by references to the
name of Hansen). Copies of the amended and restated certificate of incorporation and amended and
restated bylaws are attached hereto as Exhibits 3.1 and 3.2, respectively, and incorporated herein
by reference.
Item 5.07 Submission of Matters to a Vote of Security Holders.
Hansen held its 2016 annual meeting of stockholders (the "
Annual Meeting
") on July 22,
2016.
As of the record date, May 31, 2016, there were 18,989,610 shares of Common Stock outstanding and
entitled to vote at the Annual Meeting. At the Annual Meeting, a total of 17,725,358 shares of
Common Stock, or approximately 93.34% of all of the outstanding shares of Common Stock, were
present either in person or by proxy. The number of votes cast for, against or withheld, as well as
abstentions and broker non-votes, as applicable, with respect to each proposal that was voted upon
at the Annual Meeting is set forth below. The proposals are described in detail in Hansen's
definitive proxy statement filed with the SEC on June 20, 2016.
Proposal 1.
Adoption of the Merger Agreement, which provides for the Merger in which Hansen became
a wholly owned subsidiary of Auris. Hansen's stockholders approved Proposal 1 with the following
voting results:
BROKER
FOR
AGAINST
ABSTAIN
NON-VOTE
14,083,958
109,340
2,963
3,529,097
Proposal 2.
Non-binding advisory approval of the compensation that may be paid or become payable to
Hansen's named executive officers that is based on or otherwise relates to the Merger contemplated
by the Merger Agreement. Hansen's stockholders approved Proposal 2 with the following voting
results:
BROKER
FOR
AGAINST
ABSTAIN
NON-VOTE
14,027,692
157,439
11,130
3,529,097
Proposal 3.
Approval of the adjournment of the Annual Meeting to a later date or time if necessary
or appropriate, as determined by Hansen, to solicit additional proxies for the adoption of the
Merger Agreement if there are insufficient votes at the time of the Annual Meeting, or any
adjournment or postponement thereof, to adopt the Merger Agreement. Hansen's stockholders approved
Proposal 3 with the following voting results:
BROKER
FOR
AGAINST
ABSTAIN
NON-VOTE
14,013,095
179,531
3,635
3,529,097
Proposal 4.
Election of Directors. The following nominees received the highest number of "FOR"
votes and, as a result, were elected to serve as Class I directors. The votes cast by Hansen's
stockholders were as follows:
NOMINEE
FOR
WITHHELD
BROKER NON-VOTE
Marjorie L. Bowen
13,997,521
198,740
3,529,097
Kevin Hykes
14,106,675
89,586
3,529,097
Nadim Yared
14,105,751
90,510
3,529,097
Proposal 5
. Ratification of the appointment by the Audit Committee of the Board of BDO USA, LLP as
Hansen's independent registered public accounting firm for the fiscal year ending December 31,
2016. Hansen's stockholders approved Proposal 5 with the following voting results:
BROKER
FOR
AGAINST
ABSTAIN
NON-VOTE
17,402,210
246,287
76,861
—
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
Number
Document
2.1
Agreement and Plan of Merger dated as of April 19, 2016, by and among
Hansen Medical, Inc., Auris Surgical Robotics, Inc. and Pineco
Acquisition Corp. (incorporated by reference to Exhibit 2.1 to the
Current Report on Form 8-K filed by Hansen Medical, Inc. on April 20,
2016).
3.1
Amended and Restated Certificate of Incorporation of Hansen Medical, Inc.
3.2
Amended and Restated Bylaws of Hansen Medical, Inc.
Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
	registrant has duly caused this report to be signed on its behalf by the
	undersigned hereunto duly authorized.
Hansen Medical, Inc.
July 27, 2016
By:
/s/ Christopher P. Lowe
Name: Christopher P. Lowe
Title: Interim Chief Financial Officer
Top of the Form
Exhibit Index
Exhibit No.
Description
3.1
Amended and Restated Certificate of Incorporation of Hansen Medical, Inc.
3.2
Amended and Restated Bylaws of Hansen Medical, Inc.